3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
7
Colonic Neoplasms
5
Pancreatic Neoplasms
3
Pain, Postoperative
3
Inflammatory Bowel Diseases
3
Diverticulitis
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Male Urogenital Diseases
2
Leiomyoma
2
Inflammation
2
Carcinoma, Non-Small-Cell Lung
2
Agnosia
2
Abdominal Cancer
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Skin Neoplasms
1
Shoulder Pain
1
Respiration Disorders
1
Psychological Well-Being
1
Postoperative Complications
1
Post-thoracotomy Pain Syndrome
1
Pleural Diseases
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Cisplatin
55
Radiotherapy
33
Cetuximab
25
Paclitaxel
23
Carboplatin
23
Radiotherapy, Intensity-Modulated
21
pembrolizumab
19
Docetaxel
17
Fluorouracil
16
Nivolumab
14
Drug Therapy
11
Radiation
9
Erlotinib Hydrochloride
8
Blood Specimen Collection
8
durvalumab
7
Magnetic Resonance Spectroscopy
7
Surveys and Questionnaires
6
atezolizumab
5
Surgical Procedures, Operative
5
Radiosurgery
5
Esophagectomy
5
Chemoradiotherapy
5
olaparib
4
dacomitinib
4
Leucovorin
4
Cyclophosphamide
4
Capecitabine
4
Biopsy
4
Afatinib
4
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Squamous Cell
×
Tea
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled